1-9 of 9
Keywords: cardiovascular disease
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Biosci Rep (2021) 41 (1): BSR20203387.
Published: 22 January 2021
... mechanisms underlying the effects of ghrelin on the cardiovascular system have not been fully elucidated, and no specific therapeutic agent has been established. It is important to further explore the pharmacological potential of ghrelin pathway modulation for the treatment of cardiovascular diseases...
Biosci Rep (2019) 39 (11): BSR20190966.
Published: 12 November 2019
... in pathophysiological processes of cancer and neurodegenerative, autoimmune, and cardiovascular diseases (CVDs). In recent years, emerging challenges for intervention studies on ischemic heart diseases have received much attention. LncRNAs have a key function in the alleviation of myocardial infarction (MI) injury...
Biosci Rep (2019) 39 (8): BSR20190299.
Published: 07 August 2019
...) with atherosclerotic, cardiovascular disease. So far, a link between common genetic variations of the SGLT2 encoding gene SLC5A2 and glucose homeostasis as well as cardiovascular disease has not been established. The present study, therefore, aimed to investigate SLC5A2 single nucleotide polymorphisms (SNPs...
Includes: Supplementary data
Biosci Rep (2019) 39 (7): BSR20190267.
Published: 19 July 2019
...Siobhan M. Craige; Kai Chen; Robert M. Blanton; John F. Keaney, Jr; Shashi Kant Cardiometabolic syndrome (CMS) describes the cluster of metabolic and cardiovascular diseases that are generally characterized by impaired glucose tolerance, intra-abdominal adiposity, dyslipidemia, and hypertension...
Biosci Rep (2019) 39 (4): BSR20190213.
Published: 02 April 2019
... 13 03 2019 © 2019 The Author(s). 2019 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . apolipoprotein B-depleted serum cardiovascular disease...
Biosci Rep (2019) 39 (1): BSR20180201.
Published: 11 January 2019
... BY) . antisense oligonucleotides angiotensinogen cardiovascular disease hypertension The renin–angiotensin system is an important regulator of many physiological and pathophysiological functions. Drugs inhibiting angiotensin-converting enzyme (ACE) to decrease angiotensin II (AngII) production...
Biosci Rep (2018) 38 (6): BSR20181610.
Published: 21 December 2018
...Fei Luo; Tao Wang; Lini Zeng; Shanshan Zhu; Wenjun Cao; Wei Wu; Hongfu Wu; Tangbin Zou Cardiovascular disease (CVD) is a major killer of the human population around the world. Identifying effective diagnostic biomarkers for CVDs is particularly important in order to guide optimizing treatment...
Includes: Supplementary data
Biosci Rep (2018) 38 (2): BSR20180144.
Published: 13 April 2018
... of cardiovascular disease development. Cholesterol efflux capacity (CEC) is the key metric for determining the antiatherosclerotic function of HDL. However, the assay methods currently used to calculate CEC are not ideal for clinical use as they require the culture of cells. In the present study, we developed...
Biosci Rep (2013) 33 (1): e00005.
Published: 06 December 2012
... in the circulation. They may be useful as new biomarkers to assess the risk of CVD (cardiovascular disease). 1 To whom correspondence should be addressed (email mtozuka.alc@tmd.ac.jp ). 4 9 2012 1 10 2012 9 10 2012 16 10 2012 © 2013 The Author(s). 2013 This is an Open Access...